CHRYSALIN

What this means for you

Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

90169585

Registration number

7507922

Mark type

Stylized text

Filed

09 Sept 2020

Published for opposition

13 Apr 2021

Registered

17 Sept 2024

Attorney of record

Shannon T. Vale

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)

Owner

• Chrysalis BioTherapeutics, Inc., Galveston, TX, US
• Chrysalis BioTherapeutics, Inc., Galveston, TX, US
• Chrysalis BioTherapeutics, Inc., Galveston, TX, US

Prosecution history

• 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
• 11 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 11 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 19 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
• 05 Jun 2024 — USE AMENDMENT FILED
• 19 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 05 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
• 01 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Nov 2023 — SOU EXTENSION 5 GRANTED
• 30 Nov 2023 — SOU EXTENSION 5 FILED
• 30 Nov 2023 — SOU TEAS EXTENSION RECEIVED
• 08 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 06 Jun 2023 — SOU EXTENSION 4 GRANTED
• 06 Jun 2023 — SOU EXTENSION 4 FILED